Skip to content
TrialScanner

NCT00035581

Safety and Efficacy of Ampligen in the Treatment of HIV Patients Failing HAART

Phase 2TerminatedAIMLead

Registry record

Lead sponsor
AIM ImmunoTech Inc.
Conditions
HIV Seropositivity; HIV Infection
Primary completion
Sep 2005Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT00035581 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT00035581: Safety and Efficacy of... | TrialScanner